Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye

Phase 4

Completed

• Conditions: Dry Eye
• Interventions: Other: Systane; Other: Optive

• Registration Number: NCT00724412
• Lead Sponsor: Alcon Research

Brief Summary

Comparison of two Dry Eye products

Detailed Description

Not available

Study Timeline

• Study Start: 2008-04
• Study First Submitted: 2008-07-25
• Study First Submitted QC: 2008-07-28
• Study First Posted: 2008-07-29
• Primary Completion: 2009-02
• Study Completion: 2009-02
• Status Verified: 2012-01
• Last Update Submitted: 2012-01-31
• Last Update Posted: 2012-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 279

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Systane	Systane	Systane
Optive	Optive	Optive

Primary Outcome Measures

Name	Time	Method
Tear Break-up time	42 days